Showing results (11-20 of 62) with videos related to
Sort By:
Pageof 7
Infection and Immunity|March 26, 2003
Molecular characterization of the prototrophic Salmonella mutants defective for intraepithelial replicationAkamol E Suvarnapunya, Daniel V Zurawski, Rebecca L Guy, et al.Infection and Immunity|September 22, 2006
OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulenceDaniel V Zurawski, Chieko Mitsuhata, Karen L Mumy, et al.Methods in Molecular Biology (Clifton, N.J.)|February 25, 2019
Skin and Soft Tissue Models for Acinetobacter baumannii InfectionDaniel V Zurawski, Jaideep Banerjee, Yonas A Alamneh, et al.Antimicrobial Agents and Chemotherapy|August 2, 2012
Antibacterial activities of iron chelators against common nosocomial pathogensMitchell G Thompson, Brendan W Corey, Yuanzheng Si, et al.Gut Microbes|March 10, 2017
The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulenceShoshana Barnoy, Hanan Gancz, Yuewei Zhu, et al.Molecular Microbiology|November 20, 2008
Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma proteinDaniel V Zurawski, Karen L Mumy, Christina S Faherty, et al.Antimicrobial Agents and Chemotherapy|July 20, 2016
Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound InfectionsJames M Regeimbal, Anna C Jacobs, Brendan W Corey, et al.Infection and Immunity|October 20, 2020
GigC, a LysR Family Transcription Regulator, Is Required for Cysteine Metabolism and Virulence in Acinetobacter baumanniiMichael J Gebhardt, Daniel M Czyz, Shweta Singh, et al.ACS Chemical Biology|October 18, 2013
Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistanceTyler L Harris, Roberta J Worthington, Lauren E Hittle, et al.Msphere|June 30, 2023
Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (InvaplexAR) vaccinesK Ross Turbyfill, Kristen A Clarkson, Edwin V Oaks, et al.Pageof 7